Dr. Megan H. Hyland, MD, MS, is an Assistant Professor at the University of Rochester Medical Center. Dr. Hyland graduated from Rensselaer Polytechnic Institute with a degree in biomedical engineering and worked as a reliability engineer prior to attending medical school. She completed her medical degree, medicine internship and neurology residency at the University of Rochester, followed by a fellowship in Neuroimmunology at the Cleveland Clinic. She simultaneously received her Masters Degree in Clinical Investigation through Case Western Reserve University.

Dr. Hyland returned to Rochester in 2012 after fellowship completion and became co-Medical Director of the Rochester Multiple Sclerosis Center in 2014. In that role, she is passionate about improving access to specialized comprehensive care for patients with multiple sclerosis and similar diseases, such as neuromyelitis optica, neurosarcoidosis, and autoimmune encephalitis. Dr. Hyland is also the co-chair of the Clinical Advisory Committee for the Upstate New York Chapter of the National MS Society.

Dr. Hyland is involved in several clinical trials investigating multiple sclerosis therapies--both symptomatic treatments and therapies designed to slow or halt disease progression. She is evaluating the use of telemedicine as an alternate means of providing care to MS patients. Her research interests also include epidemiological studies in MS and analysis of large patient databases to answer clinical questions not easily assessed through clinical trials.

Certified Specialties

Neurology - American Board of Psychiatry & Neurology

Faculty Appointments

Associate Professor (Part-Time) - Department of Neurology, Neuroimmunology (SMD)

Credentials

Residency & Fellowship

Fellowship, Cleveland Clinic Foundation. 2010 - 2012

Residency, Neurology, University of Rochester Medical Center. 2007 - 2010

Internship, Internal Medicine, University of Rochester Medical Center. 2006 - 2007

Education

MD | University of Rochester School of Medicine/Dentistry (USA). 2006

Awards

National MS Society Professional on the Move. 2016

Edward T Mulligan, MD Memorial Award. 2010

Leopold L Balleisen Prize. 2001

Paul B Daitch Memorial Award. 2001

Publications

Journal Articles

Agreement Between Published Reference Resources for Neurofilament Light Chain Levels in People With Multiple Sclerosis.

Sotirchos ES, Hu C, Smith MD, Lord HN, DuVal AL, Arrambide G, Montalban X, Akgün K, Ziemssen T, Naismith RT, Hersh CM, Hyland M, Krupp LB, Nicholas JA, Bermel RA, Mowry EM, Calabresi PA, Fitzgerald KC

Neurology.. 2023 December 4101 (23):e2448-e2453. Epub 12/04/2023.

Associations of sNfL with clinico-radiological measures in a large MS population.

Sotirchos ES, Fitzgerald KC, Singh CM, Smith MD, Reyes-Mantilla M, Hersh CM, Hyland MH, Canissario R, Simmons SB, Arrambide G, Montalban X, Comabella M, Naismith RT, Qiao M, Krupp LB, Nicholas JA, Akgün K, Ziemssen T, Rudick R, Fisher E, Bermel RA, Mowry EM, Calabresi PA

Annals of clinical and translational neurology.. 2023 January 10 (1):84-97. Epub 11/25/2022.

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions.

Cohen JA, Bermel RA, Grossman CI, Hersh CM, Hyland M, Mowry EM, Naismith R, Naylor ML, Nicholas J, Rajbhandar R, Singh CM, Tintorè M, Zabalza A, Ziemssen T, Williams JR, Montalban X

Multiple sclerosis : clinical and laboratory research.. 2022 June 28 (7):1131-1137. Epub 01/07/2022.

Teleconsultation will replace most face-to-face interactions in the multiple sclerosis clinic - Yes.

Hyland MH, Robb JF

Multiple sclerosis : clinical and laboratory research.. 2021 February 27 (2):174-175. Epub 12/16/2020.

Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study.

Naismith RT, Bermel RA, Coffey CS, Goodman AD, Fedler J, Kearney M, Klawiter EC, Nakamura K, Narayanan S, Goebel C, Yankey J, Klingner E, Fox RJ,

Neurology.. 2021 January 2696 (4):e491-e500. Epub 12/02/2020.

Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 1: From the National Multiple Sclerosis Society Case Conference Proceedings.

Anadani N, Hyland M, Cruz RA, Lisak R, Costello K, Major EO, Jassam Y, Meltzer E, Varkey TC, Parsons MS, Goodman AD, Graves JS, Newsome S, Zamvil SS, Frohman EM, Frohman TC

Neurology® neuroimmunology & neuroinflammation.. 2021 January 8 (1)Epub 12/15/2020.

Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS.

Hersh CM, Kieseier B, de Moor C, Miller DM, Campagnolo D, Williams JR, Fitzgerald KC, Xiong K, McGinley MP, Hyland M, Rudick RA, Ziemssen T, Koulinska I

Multiple sclerosis journal - experimental, translational and clinical.. 2021 7 (2):20552173211004634. Epub 04/15/2021.

The impact of cognitive rehabilitation on quality of life in multiple sclerosis: A pilot study.

Munger KC, Martinez AP, Hyland MH

Multiple sclerosis journal - experimental, translational and clinical.. 2021 7 (3):20552173211040239. Epub 08/26/2021.

Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis.

Wang Y, Tian F, Fitzgerald KC, Bhattarai JJ, Naismith RT, Hyland M, Calabresi PA, Mowry EM

Multiple sclerosis and related disorders.. 2020 June 41 :102010. Epub 02/14/2020.

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS).

Mowry EM, Bermel RA, Williams JR, Benzinger TLS, de Moor C, Fisher E, Hersh CM, Hyland MH, Izbudak I, Jones SE, Kieseier BC, Kitzler HH, Krupp L, Lui YW, Montalban X, Naismith RT, Nicholas JA, Pellegrini F, Rovira A, Schulze M, Tackenberg B, Tintore M, Tivarus ME, Ziemssen T, Rudick RA

Frontiers in neurology. 2020 11 :632. Epub 08/07/2020.

Comparison of telemedicine versus in-person visits for persons with multiple sclerosis: A randomized crossover study of feasibility, cost, and satisfaction.

Robb JF, Hyland MH, Goodman AD

Multiple sclerosis and related disorders.. 2019 November 36 :101258. Epub 05/06/2019.

Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions.

Hyland M, Bermel RA, Cohen JA

Neurology. Clinical practice.. 2013 February 3 (1):15-21. Epub 1900 01 01.

Multiple sclerosis: new insights in pathogenesis and novel therapeutics.

Ontaneda D, Hyland M, Cohen JA

Annual review of medicine.. 2012 63 :389-404. Epub 09/01/2011.

Fingolimod.

Hyland MH, Cohen JA

Neurology. Clinical practice.. 2011 December 1 (1):61-65. Epub 1900 01 01.

Challenges to clinical trials in multiple sclerosis: outcome measures in the era of disease-modifying drugs.

Hyland M, Rudick RA

Current opinion in neurology.. 2011 June 24 (3):255-61. Epub 1900 01 01.

Pearls & Oy-sters: a stroke of luck: detecting type A aortic dissection by MRA.

Hyland MH, Holloway RG

Neurology.. 2011 February 2276 (8):e31-3. Epub 1900 01 01.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

During this visit, did this provider spend enough time with you?

5.0

During this visit, did this provider show respect for what you had to say?

5.0

During this visit did this provider give you easy to understand information about these health questions or concerns?

4.9

During this visit, did this provider listen carefully to you?

4.9

During this visit, did this provider explain things in a way that was easy to understand?

5.0

Patient Comments

Dr. Hyland discussed my condition changes and made recommendations for treatment.

Sep 11, 2024

5.0

Dr. Hyland is always helpful, listens and explains everything well. I get detailed answers to my questions in a manner that I can understand. Very happy with Dr Hyland.

Jul 13, 2024

5.0

I am very happy with the care Megan Hyland gives me

May 02, 2024

5.0

Dr. Hyland is an amazing doctor. Really listens and takes time with her patient I am very happy she is my doctor.

Mar 19, 2024

5.0

I have seen Dr. Hyland for over 10 years my relationship with her is as comfortable as an old shoe.

Feb 26, 2024

5.0

The doctor explained everything to me.

Feb 16, 2024

5.0

Dr. Hyland is fantastic. I always find her to be knowledgeable, kind, has wonderful sense of humor and easy to talk with.

Aug 15, 2023

5.0

Very good experience.

Aug 04, 2023

5.0

I have recommended the M.S. Clinic in general to a few people. I could never switch doctors.

Mar 25, 2023

5.0

Dr. Hyland is terrific.

Dec 05, 2022

5.0

I have recommended Dr. Hyland to some friends.

Sep 20, 2022

5.0

She is the best

Jul 27, 2022

Dr. Hyland is an outstanding doctor. She always listens to my concerns. She explains things in a manner that I can understand.

Jul 24, 2022

5.0

I was very impressed with this provider.

Jul 19, 2022

4.6

Whereas parts of the visit were confusing, I do think this is inherent in any new MS diagnosis. It's a tough diagnosis to make. Could have been helpful for her to write down names of possible medications, as the names are tough to follow.

Jul 05, 2022

5.0

She is a excellent doctor!!

May 27, 2022

5.0

I am very happy with this provider. [...]

May 27, 2022

5.0

Dr. Hyland is amazing. I have seen her twice and both times she spent a good amount of time with me discussing test results, my questions/concerns, and future plans.

Apr 18, 2022

5.0

Offered me ample time, thoroughly answered questions in an easy to understand/digest way, kind, knowledgeable, active and responsive listener.

Mar 25, 2022